- Concept and Regulatory Approach
- Protocol Design
- Program Development
With the ever-increasing complexity of Phase I trials, we have you covered.
Learn about our Phase I servicesWe specialize in designing and executing customized studies that drive your drug development forward. Our Phase I and clinical pharmacology services are tailored to meet the specific needs of your program, whether it’s a challenging study design or a unique objective.
Our commitment starts with our first conversation and lasts throughout our entire working relationship. You’ll see it in the dedication of our staff, the flexibility and availability of our leadership team, and the services you receive.
It is our mission to deliver quality data faster, allowing your asset to accelerate to the next step.
Sponsor Audit Pass Rate
Bed, Highly Flexible, Fit-for-Purpose Clinical Research Unit
Dose Full On-Time
No two studies are the same, and neither are their paths to success. We’re committed to offering bespoke support at every stage of your clinical development journey.
Our 200-bed, highly flexible, fit-for-purpose clinical pharmacology unit in San Antonio, Texas, includes the following to accommodate your study’s needs:
We know our people, processes, and technologies can play a key role in your asset’s success. This understanding is at the heart of our continuous innovation initiative—WorldwideEdge™.
Clinical Leader announced the 2024 Leadership Awards, supported by data from ISR Reports, naming Worldwide Clinical Trials the highest-rated Phase I Service Provider for Overall User Preference and the highest-rated Phase I Service Provider for Data Management.
We understand that no two Phase I trials are the same. That’s why we offer flexible, customized solutions through our state-of-the-art bioanalytical laboratory, full-service, fit-for-purpose clinical pharmacology unit, and specialized pharmacy services. With an unwavering commitment to excellence, we deliver high-quality data faster, ensuring your asset progresses seamlessly to the next phase without compromise.
Chief Scientific Officer, Early Phase Development
Executive Vice President and General Manager, Early Phase
Senior Vice President, Clinical Operations Early Phase
Senior Director, Project Management Early Phase
Worldwide Clinical Trials has access to more than 2,000 validated assays.